Mirna Samara Dié Alves

Ms. Mirna Samara Dié Alves

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
CSCaroline Carapina da Silva
Caroline Carapina da Silva
BPBruna Silveira Pacheco
Bruna Silveira Pacheco
RNRaquel Nascimento das Neves
Raquel Nascimento das Neves
MAMirna Samara Dié Alves
Mirna Samara Dié Alves
ÂSÂngela Sena-Lopes
Ângela Sena-Lopes
CPClaudio Martin Pereira de Pereira
Claudio Martin Pereira de Pereira
Trichomoniasis is a parasitic infection caused by Trichomonas vaginalis and it is considered to be the most common non-viral sexually transmitted infection in the world. Since the 1960s, nitroimidazoles such as metronidazole are the drugs of choice for the treatment of trichomoniasis, but many adverse effects and allergic reactions may result from their use. Reports of metronidazole-resistant infections also highlight the importance for the search of new anti-T. vaginalis agents. Considering this, herein we report the anti-T. vaginalis evaluation of 21 synthetic monocarbonyl analogues of curcumin, which itself has been reported to possess antiparasitic potential. From the in vitro analysis of the synthetic molecules, untreated trophozoites, and metronidazole at 100 μM, it was observed that three curcumin analogues (3a, 3e, and 5e) exhibited anti-T. vaginalis activity comparable to metronidazole (no significant statistical difference). Optimal antiparasitic concentrations were determined to be 80 μM and 90 μM for propanone derivatives 3a and 3e, respectively, and 200 μM for cyclohexanone derivative 5e. Kinetic growth curves showed that, after 24 h, the trophozoites were completely inhibited. At the tested concentrations, natural curcumin did not significantly inhibit the growth of trophozoites, therefore demonstrating that the designed synthetic molecules not only have better chemical stability, but also higher anti-T. vaginalis potential. Cytotoxicity analysis, performed on VERO cells, demonstrated low, moderate and high cytotoxic effects for analogues 3e, 5e and 3a, respectively. This study suggests that these analogues possess chemical features of interest to be further explored as alternatives for the treatment of trichomoniasis.

11 February 2020 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
MAMirna Samara Dié Alves
Mirna Samara Dié Alves
RNRaquel Nascimento das Neves
Raquel Nascimento das Neves
ÂSÂngela Sena-Lopes
Ângela Sena-Lopes
MDMicaela Domingues
Micaela Domingues
ACAngela Maria Casaril
Angela Maria Casaril
SBSibele Borsuk
Sibele Borsuk
Background: Trichomonas vaginalisis the causative agent of trichomoniasis, which is one of the most common sexually transmitted diseases worldwide. Trichomoniasis has a high incidence and prevalence and is associated with serious complications such as HIV transmission and acquisition, pelvic inflammatory disease and preterm birth. Although trichomoniasis is treated with oral metronidazole (MTZ), the number of strains resistant to this drug is increasing (2.5–9.6%), leading to treatment failure. Therefore, there is an urgent need to find alternative drugs to combat this disease.Methods: Herein, we report thein vitroandin silicoanalysis of 12 furanylN-acylhydrazone derivatives (PFUR 4, a-k) againstTrichomonas vaginalis.Trichomonas vaginalisATCC 30236 isolate was treated with seven concentrations of these compounds to determine the minimum inhibitory concentration (MIC) and 50% inhibitory concentration (IC50). In addition, compounds that displayed anti-T. vaginalisactivity were analyzed using thiobarbituric acid reactive substances (TBARS) assay and molecular docking. Cytotoxicity analysis was also performed in CHO-K1 cells.Results: The compounds PFUR 4a and 4b, at 6.25 µM, induced complete parasite death after 24 h of exposure with IC50of 1.69 µM and 1.98 µM, respectively. The results showed that lipid peroxidation is not involved in parasite death. Molecular docking studies predicted strong interactions of PFUR 4a and 4b withT. vaginalisenzymes, purine nucleoside phosphorylase, and lactate dehydrogenase, while only PFUR 4b interactedin silicowith thioredoxin reductase and methionine gamma-lyase. PFUR 4a and 4b led to a growth inhibition (< 20%) in CHO-K1 cells that was comparable to the drug of choice, with a promising selectivity index (> 7.4).Conclusions: Our results showed that PFUR 4a and 4b are promising molecules that can be used for the development of new trichomonacidal agents forT. vaginalis.

23 February 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
NSNicole Ramos Scholl
Nicole Ramos Scholl
MSMara Thais de Oliveira Silva
Mara Thais de Oliveira Silva
TBTallyson Nogueira Barbosa
Tallyson Nogueira Barbosa
RPRodrigo Barros de Pinho
Rodrigo Barros de Pinho
MAMirna Samara Dié Alves
Mirna Samara Dié Alves
SBSibele Borsuk
Sibele Borsuk
Caseous lymphadenitis is a chronic contagious disease that causes economic losses worldwide. Treatments are ineffective, thus demonstrating the importance of vaccination. In this study, rNanH and rPknG proteins from Corynebacterium pseudotuberculosis were associated with saponin or aluminum hydroxide adjuvants. Three experimental groups (10 animals each) were immunized with sterile 0.9% saline solution (G1), rNanH + rPknG + Saponin (G2), rNanH + rPknG + Al(OH)3 (G3). The mice received two vaccine doses 21 days apart. Animals were challenged 21 days after the last immunization and evaluated for 50 days, with endpoint criteria applied when needed. The total IgG production levels of the experimental groups increased significantly on day 42 when compared to the control (p < 0.05). When tested against rNanH, G2 had a better rate of anti-rNanH antibodies compared to G3. In the anti-rPknG ELISA, the levels of total IgG, IgG1, and IgG2a antibodies were higher in G2. The vaccines generated partial protection, with 40% of the animals surviving the challenge. The association of recombinant NanH and PknG proteins led to promising protection rates in mice, and although using different adjuvants did not interfere with the survival rate, it influenced the immune response generated by the vaccine formulations.

2 December 2025 in Veterinary Parasitology
Verified
Journal Article
Closed access
RMRenata Cristina Borges da Silva Macedo
Renata Cristina Borges da Silva Macedo
MAMirna Samara Dié Alves
Mirna Samara Dié Alves
FNFrancisco Chagas Barbalho Neto
Francisco Chagas Barbalho Neto
PFPablo Leandro Filgueira Feitosa
Pablo Leandro Filgueira Feitosa
MMMário Luan Silva de Medeiros
Mário Luan Silva de Medeiros
ABAna Carla Diógenes Suassuna Bezerra
Ana Carla Diógenes Suassuna Bezerra